Promus PREMIER™ H7493952838300Recalls & reported problems
Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3
All models of Promus PREMIER (56)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 13
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 13 adverse event reports that list this exact device (DI 08714729845027), received between Feb 15, 2017 and May 7, 2020 — classified as 2 injuries, 11 malfunctions.
The most frequently reported specific device problem is “Bent” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Bent3
- Break3
- Device Damaged Prior to Use2
- Entrapment of Device2
- Occlusion Within Device2
- Component Incompatible1
- Device Contamination with Chemical or Other Material1
- Device Dislodged or Dislocated1
Patient problems
- No Consequences Or Impact To Patient6
- No Patient Involvement3
- No Known Impact Or Consequence To Patient2
- Angina1
- Cardiac Enzyme Elevation1
- Reocclusion1
Recent adverse event reports
The 13 most recent of 13 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 7, 2020Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT STENT DISLODGEMENT OCCURRED. A 3.00X38MM PROMUS PREMIER DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. HOWEVER, WHILE LOADING THE DELIVERY SYSTEM ONTO A NON-BSC GUIDEWIRE, THE STENT CAME OFF THE BALLOON. THE STENT DELIVERY SYSTEM WAS PULLED OUT OFF THE WIRE AND THE PROCEDURE WAS COMPLETED WITH A 3.00X32MM SYNERGY DRUG-ELUTING STENT. NO PATIENT COMPLICATIONS NOR INJURIES WERE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10036566 ↗InjuryJun 28, 2018Occlusion Within Device; Occlusion Within Device
SAME CASE AS MDR ID # 2134265-2018-06112. IT WAS REPORTED THAT IN-STENT RESTENOSIS (ISR) OCCURRED. IN (B)(6) 2012 A 3.5X32MM PROMUS ELEMENT EVEROLIMUS-ELUTING CORONARY STENT SYSTEM WAS IMPLANTED IN THE SAPHENOUS VEIN GRAFT(SVG) AND IN (B)(6) 2016 A 3.00X38MM PROMUS PREMIER¿ STENT WAS IMPLANTED PARTIALLY OVERLAPPING THE PROMUS ELEMENT. IN (B)(6) 2018 THE STENTS WERE NOTED TO HAVE RESTENOSED. A 10MMX3.00MM WOLVERINE¿ CORONARY CUTTING BALLOON® MONORAIL® WAS ADVANCED IN AN ATTEMPT TO DILATE AND FAILED TO CROSS THE ISR. THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: Reocclusion
MAUDE report 7645708 ↗MalfunctionMar 13, 2018Break; Break
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. A 3.00X38MM PROMUS PREMIER¿ STENT WAS SELECTED FOR USE. THE DEVICE WAS LOADED ONTO THE WIRE AND WHILE INSERTING IT INTO THE SHEATH, IT WAS NOTED THAT THE SHAFT BROKE. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7334144 ↗MalfunctionFeb 8, 2018Component Incompatible; Component Incompatible
REPORTABLE BASED ON DEVICE ANALYSIS COMPLETED ON 15-JAN-2018. IT WAS REPORTED THAT CONNECTION INCOMPATIBILITY OCCURRED. A 3.00 X 38 MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS SELECTED FOR USE. HOWEVER, WHEN THE STENT DELIVERY SYSTEM (SDS) WAS CONNECTED TO A BSC INFLATION DEVICE, THE SDS WOULD NOT CONNECT SECURELY. THE PROCEDURE WAS COMPLETED WITH ANOTHER 3.0 X 38 MM PROMUS DRUG-ELUTING STENT. NO PATIENT COMPLICATIONS WERE REPORTED. HOWEVER, RETURNED DEVICE ANALYSIS REVEALED A DETACHED/SEPARATED STENT.
Patient problems: No Patient Involvement
MAUDE report 7251278 ↗MalfunctionOct 12, 2017Break; Break
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. THE TARGET LESION WAS LOCATED IN A CORONARY ARTERY. AFTER A GUIDE WAS PLACED IN THE LESION, A 3.00X38MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS ATTEMPTED TO BE ADVANCED BUT THE SHAFT OF THE STENT BROKE AT ABOUT MIDWAY UP. THE BREAK OCCURRED OUTSIDE THE PATIENT'S BODY SO THE DEVICE WAS ABLE TO BE REMOVED WITHOUT PROBLEM. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS FINE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6944241 ↗MalfunctionJun 20, 2017Break; Device Damaged Prior to Use; Break; Device Damaged Prior to Use
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. DURING PREPARATION OF A 3.00X38MM PROMUS PREMIER¿ DRUG-ELUTING STENT, IT WAS NOTED THAT THE HYPOTUBE WAS FRACTURED AND BROKEN. THE DEVICE WAS NOT USED INSIDE THE PATIENT AND THE PROCEDURE WAS COMPLETED WITH A 3.0X38MM PROMUS PREMIER STENT. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Patient Involvement
MAUDE report 6654179 ↗MalfunctionApr 18, 2017Entrapment of Device; Entrapment of Device
SAME CASE AS MDR ID: 2134265-2017-03358. IT WAS REPORTED THAT CATHETER ENTRAPMENT OCCURRED. A 2.50X16MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS SELECTED FOR USE TO TREAT A LESION. HOWEVER, DURING PREPARATION, THE STENT CAME OUT OF ITS HOOP WITH THE EDGE OF THE STENT STRUTS DEFORMED. THE DEVICE WAS NOT USED INSIDE THE PATIENT. A 3.00X38MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS THEN ADVANCED TO TREAT THE LESION. HOWEVER, DURING THE PROCEDURE THE DEVICE BECAME STUCK WITH THE NON-BSC GUIDE EXTENSION CATHETER. THE PROCEDURE WAS COMPLETED USING A DIFFERENT DEVICE. THERE WERE NO PATIENT COMPLICATIONS NOR HARM REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6499611 ↗MalfunctionApr 11, 2017Bent; Device Damaged Prior to Use; Bent; Device Damaged Prior to Use
IT WAS REPORTED THAT STENT DAMAGE OCCURRED. DURING PREPARATION OF A 3.00X38MM PROMUS PREMIER¿ DRUG-ELUTING STENT, WHEN THE DEVICE WAS REMOVED FROM THE HOOP AND PROTECTOR, IT WAS NOTED THAT ONE OF THE STENT STRUT WAS BENT. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Patient Involvement
MAUDE report 6481978 ↗MalfunctionApr 5, 2017Bent; Bent
IT WAS REPORTED THAT STENT DAMAGE OCCURRED. THE TARGET LESION WAS LOCATED IN A CORONARY ARTERY. A 3.00X38MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS ADVANCED TO TREAT THE LESION. HOWEVER, THE STENT WAS FRAYED AND THE DEVICE FAILED TO CROSS THE LESION. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 6459856 ↗InjuryApr 3, 2017Occlusion Within Device; Occlusion Within Device
IT WAS REPORTED THAT STENT RESTENOSIS OCCURRED AND THE PATIENT EXPERIENCED UNSTABLE ANGINA AND ELEVATED TROPONINS. IN (B)(6) 2014 3.00 X 38 MM PROMUS PREMIER¿ STENT WAS IMPLANTED IN THE LEFT ANTERIOR DESCENDING (LAD) ARTERY. IN (B)(6) 2017, THE PATIENT PRESENTED WITH UNSTABLE ANGINA AND SLIGHTLY ELEVATED TROPONIN LEVELS; 90% FOCAL IN-STENT RESTENOSIS (ISR) WAS NOTED. THE FOLLOWING DAY, SURGERY WAS PERFORMED AND PREDILATION WAS COMPLETED WITH A 3.00 X 15 MM BALLOON FOLLOWED BY THE IMPLANT OF A 3.50 X 20 MM SYNERGY STENT, RESULTING IN 0% STENOSIS AND RESTORED TIMI 3 FLOW. THE PATIENT WENT HOME LATER THAT DAY AN THE PHYSICIAN FELT THAT THE RESULTS WERE "EXCELLENT."
Patient problems: Angina; Cardiac Enzyme Elevation
MAUDE report 6453673 ↗MalfunctionMar 3, 2017Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material
IT WAS REPORTED THAT A FOREIGN MATTER WAS FOUND. THE TARGET LESION WAS LOCATED IN A CORONARY ARTERY. A 3.00X38MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS ADVANCED BUT FAILED TO CROSS THE LESION. AFTER SEVERAL ATTEMPTS, IT WAS NOTED THAT THERE WAS A CHUCK OF PLASTIC OBSTRUCTING THE HUB. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 6377190 ↗MalfunctionFeb 22, 2017Entrapment of Device; Entrapment of Device
IT WAS REPORTED THAT CATHETER ENTRAPMENT OCCURRED. THE TARGET LESION WAS LOCATED IN THE VESSEL BELOW THE KNEE. AFTER A GUIDEWIRE CROSSED THE LESION, A 3.00X38MM PROMUS PREMIER DRUG-ELUTING STENT WAS ADVANCED BUT THE DEVICE BECAME STUCK ON THE WIRE. BOTH OF THE DEVICES WERE REMOVED TOGETHER. USING THE SAME WIRE, A NEW PROMUS STENT WAS THEN AND ADVANCED AND DEPLOYED WHICH COMPLETED THE PROCEDURE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS FINE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6350206 ↗MalfunctionFeb 15, 2017Bent; Bent
IT WAS REPORTED THAT STENT DAMAGE OCCURRED. THE TARGET LESION WAS LOCATED IN THE RIGHT CORONARY ARTERY. A 3.00X38MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS ADVANCED BUT FAILED TO CROSS THE LESION. THE DEVICE WAS REMOVED AND WAS THEN RE-ADVANCED; HOWEVER, IT WAS NOTICED THAT ONE OF THE STENT STRUTS HAD BEEN DAMAGED AND PEELED UP. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS FINE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6332104 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page